Epidural steroid injections for pain management in spinal metastases: clinical predictors of effectiveness in a retrospective cohort study
Pain Medicine · 2026
DOI: 10.1093/pm/pnaf177 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Pain Medicine, 2026. Verfasst von Joon Hee Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea. Hauptthemen laut MEDLINE: Pain Management, Cancer Pain, Spinal Neoplasms, Steroids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Background
Cancer-related pain management remains challenging, particularly for spinal metastases, in which pain arises from multiple pathological mechanisms. Despite the increasing use of epidural steroid injections (ESI) in clinical practice as part of multimodal pain management, the evidence of their effectiveness in these patients remains limited.
Design
A retrospective cohort study.
Setting
Three university-affiliated tertiary hospitals in South Korea. Subjects A total of 123 patients with cancer and radiologically confirmed spinal metastases who underwent ESI between January 2020 and December 2022. Patients were categorized as effective (Group E, ≥50% pain reduction at 1 month, n = 73) or non-effective (Group N, n = 50).
Methods
Pain intensity, opioid use, patient satisfaction, repeat procedures, and survival were evaluated at baseline and 1 and 3 months after ESI. In addition, factors influencing the effectiveness of ESI were analyzed.
Results
A better performance status (ECOG-PS 1) and lower baseline opioid requirements predicted a favorable ESI response. The Group E maintained pain relief at 3 months with a minimal increase in opioid use, reported higher satisfaction (94.5% vs 6.5%), needed fewer repeat injections (64.4% vs 86.6%), and demonstrated better 6-month survival (78.1% vs 34.0%) than Group N.
Conclusion
ESI may be beneficial in reducing pain and attenuating opioid escalation in patients with spinal metastases, especially when the performance status is relatively preserved, and before the initiation of high-dose opioid therapy. These results support early integration of ESI into multimodal cancer pain management strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.
- Department of Anesthesiology and Pain Medicine, Seoul National University College of Medicine, Seoul, Korea.
ORCID-Profile: Joon Hee Lee, Minhye Chang, Dongsik Lim, Francis Sahngun Nahm, Pyung Bok Lee, Eun Joo Choi
Zitieren
APA
Lee, J. H., Chang, M., Lim, D., Nahm, F. S., Lee, P. B., & Choi, E. J. (2026). Epidural steroid injections for pain management in spinal metastases: clinical predictors of effectiveness in a retrospective cohort study. Pain Medicine. https://doi.org/10.1093/pm/pnaf177
Vancouver
Lee JH, Chang M, Lim D, Nahm FS, Lee PB, Choi EJ. Epidural steroid injections for pain management in spinal metastases: clinical predictors of effectiveness in a retrospective cohort study. Pain Medicine. 2026. doi:10.1093/pm/pnaf177
BibTeX
@article{Lee2026,
author = {Lee, Joon Hee and Chang, Minhye and Lim, Dongsik and Nahm, Francis Sahngun and Lee, Pyung Bok and Choi, Eun Joo},
title = {Epidural steroid injections for pain management in spinal metastases: clinical predictors of effectiveness in a retrospective cohort study},
journal = {Pain Medicine},
year = {2026},
doi = {10.1093/pm/pnaf177}
}
EUVIMED